Clinical trials
Terminated Phase 2 Lupus Erythematosus, Systemic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2008 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 5 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 4 |
| Aikaterini Thanou | 1 |
| Amgen | 1 |
| Charite University, Berlin, Germany | 1 |
| EMD Serono | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Genentech, Inc. | 1 |
| GlaxoSmithKline | 1 |
| Human Genome Sciences Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 25 |
| Autoimmune Diseases | 3 |
| Arthritis, Rheumatoid | 2 |
| Lupus Nephritis | 2 |
| Arthritis, Juvenile | 1 |
| COVID-19 | 1 |
| Dermatomyositis | 1 |
| Lupus Erythematosus, Cutaneous | 1 |
| Multiple Sclerosis | 1 |
| Myasthenia Gravis | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.